Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

henry schein inc. - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infections : due to s. pneumoniae , klebsiella  species, h. influenzae , s. aureus  (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections : due to e. coli, p. mirabilis, klebsiella  species, and some strains of enterobacter and enterococci. skin and skin structure infections : due to s. aureus  (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of str

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

civica, inc. - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infections:  due to s. penumoniae, klebsiella species, h. influenzae, s. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection, usp is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection, usp in the subsequent prevention of rheumatic fever are not available. urinary tract infections: due to e. coli, p. mirabilis, klebsiella species, and some strains of enterobacter and enterococci. skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

apotex corp. - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infections: due to s. pneumoniae , klebsiella species, h. influenzae , s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection, usp is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection, usp in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections: due to e. coli , p. mirabilis , klebsiella species, and some strains of enterobacter and enterococci. skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of streptococci. biliary tract infections: due to e. coli , various strains of streptococci, p. mirabilis , klebsiella species and s. aureus . bone and joint infections: due to s. aureus. genital infections: (i.e., prostatitis, epididymitis) due to e. coli , p. mirabilis , klebsiella species, and some strains of enterococci. septicemia: due to s. pneumoniae , s. aureus (penicillin-sensitive and penicillin-resistant), p. mirabilis , e. coli and klebsiella species. endocarditis: due to s. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-hemolytic streptococci. perioperative prophylaxis: the prophylactic administration of cefazolin for injection, usp preoperatively, intraoperatively, and postoperatively may reduce the incidence of certain postoperative infections in patients undergoing surgical procedures which are classified as contaminated or potentially contaminated (e.g., vaginal hysterectomy, and cholecystectomy in high-risk patients such as those older than 70 years, with acute cholecystitis, obstructive jaundice, or common duct bile stones). the perioperative use of cefazolin for injection, usp may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g., during open-heart surgery and prosthetic arthroplasty). the prophylactic administration of cefazolin for injection, usp should usually be discontinued within a 24 hour period after the surgical procedure. in surgery where the occurrence of infection may be particularly devastating (e.g., open-heart surgery and prosthetic arthroplasty), the prophylactic administration of cefazolin for injection, usp may be continued for 3 to 5 days following the completion of surgery. if there are signs of infection, specimens for cultures should be obtained for the identification of the causative organism so that appropriate therapy may be instituted. (see dosage and administration.) to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin for injection, usp and other antibacterial drugs, cefazolin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

wg critical care, llc - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection is indicated for perioperative prophylaxis in adult patients [see dosage and administration (2.1, 2.2, 2.3, 2.4) . the perioperative use of cefazolin for injection is indicated in adult surgical patients in whom infection at the operative site would present a serious risk (e.g., during open-heart surgery and prosthetic arthroplasty). the prophylactic administration of cefazolin for injection preoperatively, intraoperatively and postoperatively may reduce the incidence of certain postoperative infections in patients undergoing surgical procedures which are classified as contaminated or potentially contaminated (e.g., vaginal hysterectomy, and cholecystectomy in high-risk patients such as those older than 70 years, with acute cholecystitis, obstructive jaundice or common duct bile stones). pediatric use information is approved for b. braun medical’s cefazolin for injection and dextrose for injection. however, due to b. braun medical’s marketing exclusivity rights, this drug product is no

Singapūra - angļu - HSA (Health Sciences Authority)

lotus international pte. ltd. - cefazolin sodium 1.048g eqv to cefazolin - injection, powder, for solution - cefazolin sodium 1.048g eqv to cefazolin 1 g

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 1.048 g equivalent to 1 g cefazolin - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to 1 g cefazolin - cefazolin-aft is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infection: due to s. pneumoniae, klebsiella sp, h. influenzae, staph, aureus (including penicillinase-producing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin-aft is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 2.097 g equivalent to 2 g cefazolin - powder for injection - 2 g - active: cefazolin sodium 2.097 g equivalent to 2 g cefazolin - cefazolin-aft is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infection: due to s. pneumoniae, klebsiella sp, h. influenzae, staph, aureus (including penicillinase-producing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin-aft is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

general injectables & vaccines, inc - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin 1 g in 3 ml - to reduce the development of drug-resistant bacteria and maintain the effectivness of cefazolin for injection, usp and other antibacterial drugs. cefazolin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection, usp is indicated for the treatment of the following infections when caused by susceptible bacteria. 1.1 respiratory tract infections respiratory tract infections due to streptococcus pneumoniae, staphylococcus aureus and streptococcus pyogenes. injectable benzatine penicillin is considered the drug of choice in treatment and prevention of streptococcal infections, including prophylaxis of rheumatic fever. cefazolin is effective i

Kanāda - angļu - Health Canada

baxter corporation - cefazolin (cefazolin sodium) - solution - 20mg - cefazolin (cefazolin sodium) 20mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

samson medical technologies, l.l.c. - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin and other antibacterial drugs, cefazolin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection is indicated for the treatment of the following infections when caused by susceptible bacteria. respiratory tract infections due to streptococcus pneumoniae , staphylococcus aureus and streptococcus pyogenes . injectable benzathine penicillin is considered the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, dat